Low-cost Asean imports worry medical device companies

Anti-dumping probe into dialyser imports from China and Malaysia highlights concerns over low-priced medical device imports.

Imports from Asean rose 14% to nearly Rs 13,000 crore in FY25-26, including syringes, gloves, dialysis products, and imaging equipment.

Chinese-origin products enter India via Asean nations to exploit zero-duty benefits under the FTA, prompting calls to tighten rules of origin.

Dialyser imports from Malaysia and China doubled to Rs 256 crore over two years, hurting domestic manufacturers like Poly Medicure.

Industry groups urge urgent FTA renegotiation to safeguard India's medtech manufacturing base and PLI investments.